Millennium Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-556,264
Closed -$56.7M 5017
2023
Q2
$56.7M Buy
556,264
+342,204
+160% +$34.9M 0.03% 448
2023
Q1
$19.5M Sell
214,060
-549,212
-72% -$49.9M 0.01% 970
2022
Q4
$29M Buy
763,272
+141,179
+23% +$5.36M 0.02% 765
2022
Q3
$15.6M Buy
622,093
+469,627
+308% +$11.8M 0.01% 1122
2022
Q2
$4.63M Sell
152,466
-86,175
-36% -$2.62M ﹤0.01% 2229
2022
Q1
$7.82M Sell
238,641
-370,310
-61% -$12.1M ﹤0.01% 1851
2021
Q4
$16.1M Buy
608,951
+604,688
+14,185% +$15.9M 0.01% 1175
2021
Q3
$429K Buy
+4,263
New +$429K ﹤0.01% 4274
2021
Q2
Sell
-55,723
Closed -$5.56M 5539
2021
Q1
$5.56M Sell
55,723
-97,920
-64% -$9.76M ﹤0.01% 1968
2020
Q4
$19M Sell
153,643
-128,364
-46% -$15.9M 0.01% 816
2020
Q3
$27.5K Sell
282,007
-36,170
-11% -$3.52K 0.03% 423
2020
Q2
$49.6M Buy
318,177
+95,871
+43% +$15M 0.07% 196
2020
Q1
$32.1M Buy
222,306
+8,623
+4% +$1.24M 0.07% 167
2019
Q4
$43.7M Buy
213,683
+21,108
+11% +$4.32M 0.05% 317
2019
Q3
$15.5M Sell
192,575
-230,286
-54% -$18.5M 0.02% 770
2019
Q2
$39.9M Sell
422,861
-66,064
-14% -$6.23M 0.06% 364
2019
Q1
$41.8M Buy
488,925
+353,267
+260% +$30.2M 0.06% 360
2018
Q4
$7.61M Buy
135,658
+36,116
+36% +$2.03M 0.01% 1171
2018
Q3
$8.14M Buy
99,542
+90,761
+1,034% +$7.42M 0.01% 1308
2018
Q2
$307K Buy
+8,781
New +$307K ﹤0.01% 3012
2017
Q4
Sell
-37,147
Closed -$1.16M 3815
2017
Q3
$1.16M Buy
+37,147
New +$1.16M ﹤0.01% 2231
2017
Q2
Sell
-32,108
Closed -$727K 3643
2017
Q1
$727K Sell
32,108
-11,446
-26% -$259K ﹤0.01% 2361
2016
Q4
$951K Buy
+43,554
New +$951K ﹤0.01% 2093